Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trientine with LipoDox and Carboplatin in Ovarian Cancer
NCT03480750Phase 2Completed
- Sponsor
- National Cheng Kung University Hospital
- Start
- Sep 2012
- Primary completion
- Oct 2015
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of trientine in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal cancer (PPC), sponsored by National Cheng Kung University Hospital. Started Sep 2012; status: completed.
02
Drugs
trientine
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal cancer (PPC)
Beyond the preview
Go deeper on NCT03480750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03480750.